Cytotoxicity, a major obstacle in therapeutic application of antimicrobial peptides, is controlled by leucine-zipper-like sequences in melittin and other naturally occurring antimicrobial peptides. Magainin 2 shows significantly lower cytotoxicity than many naturally occurring antimicrobial peptides and lacks this structural element. To investigate the consequences of introducing a leucine zipper sequence in magainin 2, a novel analogue (Mag-mut) was designed by rearranging only the positions of its hydrophobic amino acids to include this structural element. Both magainin 2 and Mag-mut showed appreciable similarities in their secondary structures in the presence of negatively charged lipid vesicles, in localizing and permeabilizing the selected bacteria and exhibiting bactericidal activities. However, Mag-mut bound and localized strongly on to the mammalian cells tested and exhibited significantly higher cytotoxicity than magainin 2. Only Mag-mut, but not magainin 2, permeabilized human red blood cells and zwitterionic lipid vesicles. In contrast with magainin 2, Mag-mut self-assembled in an aqueous environment and bound co-operatively on to zwitterionic lipid vesicles. The peptides formed pores of different sizes on to a selected mammalian cell. The results of the present study indicate an important role of the leucine zipper sequence in the cytotoxicity of Mag-mut and demonstrate that its introduction into a non-toxic peptide, without altering the amino acid composition, can render cytotoxicity.
INTRODUCTION
In recent years the development of resistance against conventional antibiotics has triggered the demand for a new form of antiinfective molecules. Antimicrobial peptides, owing to their active persistence throughout the evolutionary scale, provide a good template for designing novel antibiotics of high therapeutic value. Although there is a large amount of literature focused towards the understanding of the mechanism of bactericidal activity of these peptides, very few reports deal with the mechanism of their toxic activity towards mammalian cells [1] [2] [3] [4] . An in-depth study of the factors which regulate the toxicity of these antimicrobial peptides is very important as toxicity is one of the major obstacles in their systemic application to treat infection. A leucine zipper motif was identified in melittin which plays a major role in its toxic activity, but does not affect its antimicrobial activity [5] . This also holds true for the cathilicidin-derived antimicrobial peptides BMAP-27 and BMAP-28 [6, 7] . Although a leucine zipper motif has been reported to assist in the assembly of DNA-binding proteins and membrane-associated viral fusion proteins [8] [9] [10] [11] , the role of this sequence in biological activities of antimicrobial peptides is not known. Novel antimicrobial peptides with modulated toxicity have been designed by using this sequence [12] . Moreover novel cell-selective analogues of melittin have been developed by substituting its heptadic leucine residues with peptoid residues [13] . Results obtained from these studies further strengthened the role of this amino acid sequence element in maintaining toxicity of these antimicrobial peptides against mammalian cells. Encouraged by these observations, we decided to investigate the consequences of creating this motif in magainin 2, an extensively studied antimicrobial peptide [14, 15] which lacks this structural element. Magainin 2, isolated from African clawed frog Xenopus laevis, possesses a broad spectrum of antimicrobial activity; it kills not only Gram-negative and Gram-positive bacteria, but also fungi and protozoa [16] . The most striking feature of magainin 2 is its low toxicity towards eukaryotic cell in comparison with many other peptides of approximately the same length, the MIC (minimum inhibitory concentration) for various micro-organisms is typically in the range of 10-100 μg/ml, whereas more than 1 mg/ml is needed to lyse erythrocytes [16] . A magainin 2 derivative, MSI-78, is in Phase III clinical trials for its use as a topical antibiotic [17] .
In the present study, the sequence of magainin 2, particularly its hydrophobic amino acids, have been rearranged in such a way as to not alter its total composition, so that the new analogue, Mag-mut (magainin mutant), contains a leucine-zipper-like motif ( Figure 1 ). Mag-mut displayed significantly increased toxicity as compared with magainin 2; however, its antimicrobial activity remained unaffected. Extensive studies have been carried out to characterize this novel analogue of magainin 2 and compare its structural and functional properties with its native peptide. The results have been discussed in terms of the contribution of a leucine-zipper-like sequence in inducing cytotoxicity in an antimicrobial peptide. side-chain-protected amino acids were purchased from Novabiochem. Coupling reagents for peptide synthesis, such as 1-hydroxybenzotriazole, DIC (N,N -diisopropylcarbodiimide), 1,1,3,3-tetramethyluronium tetrafluoroborate and N,N -diisopropylethylamine were purchased from Sigma, whereas dichloromethane, N,N -dimethylformamide and piperidine were of standard grades and obtained from local companies. Acetonitrile (HPLC grade) was obtained from Merck, whereas TFA (trifluoroacetic acid) was purchased from Sigma. Egg PC (phosphatidylcholine) and egg PG (phosphatidylglycerol) were obtained from Northern Lipids, whereas Chol (cholesterol) was purchased from Sigma. diS-C 3 -5 (3,3 -dipropylthiadicarbocyanine iodide), NBD (7-nitrobenz-2-oxa-1,3-diazole) and tetramethylrhodamine succinimidyl ester were obtained from Invitrogen (Molecular Probes). The rest of the reagents were of analytical grade and obtained locally; buffers were prepared in Milli-Q (USF ELGA) water.
Peptide synthesis, fluorescent labelling and purification
Stepwise solid-phase syntheses of all of the peptides were accomplished manually on rink amide-MBHA resin (0.15 mmol) using standard Fmoc chemistry, as described previously [5, 18] . Labelling at the N-terminus of the peptides with a fluorescent probe, cleavage of the labelled and unlabelled peptides from the resin, and their precipitation and purification by reverse-phase HPLC were achieved by standard procedures [11] . The purified peptides were ∼95 % homogeneous. Experimental molecular masses of the peptides were detected by ESI (electrospray ionization)-MS analysis.
Assay of haemolytic activity
Haemolytic activity of the peptides against hRBCs (human red blood cells) in PBS was examined to check the ability of the peptides to lyse the hRBCs, as described previously [5] .
Antibacterial activity assay
This bioassay with all of the peptides was performed in 96-well microtitre plates against different Gram-positive and Gramnegative bacteria, according to standard protocols [7] .
Cell cultures
Mammalian cell lines, murine 3T3 (mouse fibroblast cells) and CHO (Chinese-hamster ovary)-K1, were grown in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum) and antibiotics at 37
• C in a humidified atmosphere at 5 % CO 2 and 95 % air. Cells were manually counted with a haemocytometer using an Olympus CKX41 light microscope.
Cell viability assay
Viability of the cells was determined to check the toxic activity of peptides against murine 3T3 and CHO-K1 cells using a standard procedure, as described previously [19] .
Preparation of LUVs (large unilamellar vesicles)
LUVs were prepared using a standard procedure, as described previously [7] , with the required amounts of either of the PC/Chol 
Assay of peptide-induced depolarization of hRBCs and bacterial membrane
Peptide-induced depolarization of the hRBC, Staphylococcus aureus and Escherichia coli (A.T.C.C. 10536) membranes was detected by its efficacy to dissipate the potential across these cell membranes with the help of a potential-sensitive dye, diS-C 3 -5, as described previously [6, 7, 12] .
Calcein leakage from the calcein-entrapped lipid vesicles
In order to determine the destabilization of phospholipid membrane by magainin 2 and its analogue, release of calcein from calcein-entrapped lipid vesicles in the presence of these peptides was measured, as described previously [12] .
CD studies
The CD spectra of the peptides were recorded on a Jasco J-710 spectropolarimeter in PBS (pH 7.4), zwitterionic PC/Chol [8:1 (w/w)] and negatively charged PC/PG [7:3 (w/w)] lipid vesicles. The spectropolarimeter was calibrated routinely with 10-camphor sulfonic acid. The samples were scanned at room temperature (∼30
• C) with the help of a capped quartz cuvette of 0.2 cm path length at a wavelength range 250-190 nm. An average of four to six scans was taken for each sample, with a scan speed of 20 nm/min and data interval of 1 nm.
ANS (8-anilinonaphthalene-1-sulfonate)-binding experiment
ANS is an environment-sensitive fluorescence probe, which we used to detect the formation of peptide aggregates owing to self assembly of magainin and its analogue in an aqueous environment. ANS is known to have a very low fluorescence yield in an aqueous environment, and the fluorescence yield increases significantly upon transfer to a hydrophobic environment [20] . ANS was added to PBS to a final concentration of ∼20 μM, followed by addition of peptides. Change in the emission spectra was monitored in the range 400-600 nm, with the excitation wavelength set at 365 nm.
Localization of peptides on to mammalian and bacterial membranes by confocal microscopy Localization and binding of the peptides on to mammalian and bacterial membranes was studied using the rhodaminelabelled versions of peptides. Fresh hRBCs (6 % in PBS) and Bacillus megaterium [∼10 6 CFU (colony-forming units)/ml] were incubated with rhodamine-labelled peptides in PBS for 30 min and 1 h in the case of hRBCs and bacteria respectively, at 37
• C with gentle shaking. Cells were washed three times with PBS and fixed with 2% paraformaldehyde (10 min) after extensive washing with PBS, and the images of cells were taken with an argon ion laser set for Rho-excitation at 561 nm using a Zeiss confocal microscope LSM-510 Meta. The settings of the photomultiplier were constant during the whole experiments [7] .
Membrane-binding experiments
The affinity of magainin 2 and its analogue for zwitterionic PC/Chol lipid vesicles was determined by binding experiments as described previously [11] . In brief, LUVs were added gradually to a freshly dissolved NBD-labelled peptide of ∼0.20 μM concentration at room temperature. Fluorescence intensities of NBD-labelled peptides alone, and after each addition of lipid vesicles, were recorded at 528 nm with an excitation wavelength for NBD set at 467 nm on a PerkinElmer spectrofluorimeter (model LS-55B). The excitation and emission slits were fixed at 8 and 6 nm respectively. The contribution of lipid to any of the recorded signals was measured by titrating the unlabelled peptide (at the concentration of NBD-labelled peptide) with the same amount of lipid vesicles and this was subtracted from the original fluorescence signal. The binding isotherms of the phospholipid interactions of these peptides were analysed to determine their partition coefficients, as described previously [11] .
Determination of sizes of the peptide-induced pores in CHO-K1 cells
Magainin 2-and Mag-mut-induced permeabilization of CHO-K1 cells were determined using soluble fluorescent molecules [21] . Calcein, 4.4 kDa FITC-dextran, 20 kDa FITC-dextran, 40 kDa FITC-dextran, 70 kDa FITC-dextran and 250 kDa FITCdextran were added to ∼10 5 CHO-K1 cells in microcentrifuge tubes at final concentrations of 2 mM, 0.16 mg/ml, 0.32 mg/ml, 0.16 mg/ml, 0.16 mg/ml and 0.16 mg/ml respectively. Following this, magainin 2 and Mag-mut were added to the tubes at final concentrations of ∼25 μM and ∼10 μM respectively (each doped with 2 % Rho-labelled peptide). Considering the differences in their cytotoxicity, different concentrations of the peptides were used. After 2-3 min of incubation at room temperature, cells were transferred to glass slides and immediately observed under the microscope. The percentage of influx was calculated from FI (fluorescent intensity), according to the following equation (eqn 1), by examining 20-40 cells [21] :
where, FI in = FI in cells with fluorescent molecule influx, FI out = FI out of the cell and FI wi = FI in cells without fluorescent molecule influx.
RESULTS

Design of Mag-mut
On carefully looking at the amino acid sequence of magainin 2, we noticed that the stretch from Leu 6 to Ile 20 could yield a leucine-zipper-like sequence if Gly 13 is replaced with a/an leucine or isoleucine residue. The purpose of the present study was to introduce a leucine-zipper-like sequence in Mag-mut by rearranging the positions of only non-polar amino acids so that the amphipathic character, as well as the amino acid composition of the original molecule, was not disturbed. Therefore, glycine at position 13 was replaced by isoleucine at position 2, whereas the positions of phenylalanine at position 5 and alanine at position 9 were interchanged with each other, so that the amino acid stretch from 6-20 contained an ideal leucine-zipper-like sequence ( Figure 1A ). Consequently, the native magainin 2 and its new analogue possessed the same mean hydrophobicity and mean hydrophobic moment ( Figure 1A ). The calculated and experimental molecular masses of the peptides are also shown in Figure 1 (A). Hydrophobic moments according to Eisenberg's scale and predicted helix content of the peptides according to the program AGADIR [22] are also included in Figure 1 
Mag-mut exhibited enhanced cytotoxic activity
To estimate the effect of an introduced leucine zipper sequence on the toxic activity of magainin 2, a haemolytic activity assay was performed against hRBCs. Interestingly, Mag-mut exhibited significantly augmented haemolysis against hRBCs as compared with the parent peptide ( Figure 2A ). To support the validity of this observation, the toxicity of these peptides against other mammalian cell types was also investigated. The viability of murine 3T3 and CHO cells was significantly reduced in the presence of Mag-mut, whereas magainin 2 showed a comparatively lesser effect on these cells ( Figures 2B and 2C ). Taken together, the results suggested that the introduction of a leucine-zipper-like sequence in Mag-mut resulted in a significant augmentation of its cytotoxicity against both hRBCs and other mammalian cells tested, as compared with the native peptide.
Magainin 2 and Mag-mut exhibited comparable bactericidal activity
MIC values of magainin 2 and Mag-mut were determined against Gram-positive and Gram-negative bacteria in 96-well plates using a serial dilution method, as described previously [7] . Both of the peptides displayed comparable activity against the microorganisms tested (Table 1) , which indicates that the introduced leucine zipper sequence did not show any significant effect on the bactericidal activity of magainin 2.
Magainin 2 and Mag-mut exhibited differences in localization on to mammalian cells, but not to bacteria
The binding and localization of these peptides on to mammalian and bacterial cell membranes was probed by confocal microscopy by using the Rho-labelled versions of the peptides. Only Rho- labelled Mag-mut localized effectively on to the hRBCs, as seen by the prominent red fluorescence on these cell membranes ( Figure 3) . Although the cells were visible in the DIC panels, the fluorescence signal of Rho-labelled magainin 2 was too weak to visualize on these cells, which implied weak binding of this peptide to hRBC membranes. The results clearly indicate that Rho-labelled Mag-mut possesses stronger binding affinity for hRBC cell membranes in comparison with the native version. Contrary to the case of hRBCs, both of the peptides localized similarly on to the Gram-positive bacterium B. megaterium (Figure 3 ), which indicates that Rho-labelled versions of both magainin 2 and Mag-mut possess very similar affinity for the bacterial membrane.
Peptide-induced depolarization of hRBCs and bacteria
To investigate the ability of the two peptides for destabilizing the mammalian and bacterial cell membranes, peptide-induced depolarization of hRBC, and S. aureus and E. coli membranes, as indicated by the dissipation of membrane potential, was detected by using a potential sensitive dye diS-C 3 -5. Magainin 2 failed to induce appreciable depolarization in hRBC membranes, whereas Mag-mut significantly depolarized the hRBC membranes, as indicated by a plot of the percentage of fluorescence recovery against the peptide concentration ( Figure 4A ). However, both of the peptides depolarized the Gram-positive bacteria S. aureus and the Gram-negative bacteria E. coli membranes almost to a similar extent ( Figures 4B and 4C) . NBD-and Rho-labelled magainin 2 and Mag-mut exhibited comparable depolarization with their unlabelled versions in hRBCs and S. aureus (results not shown), suggesting that labelling of these peptides did not significantly affect their membrane-permeabilization properties.
Peptide-induced leakage of lipid vesicles
The permeability of zwitterionic and negatively charged lipid vesicles in the presence of magainin 2 and Mag-mut was determined by measuring the release of calcein from calceinentrapped lipid vesicles. PC/Chol [8:1 (w/w)] and PC/PG [7:3 (w/w)] lipid vesicles were used as mimetics of mammalian and bacterial cell membrane respectively, as used previously by others [23, 24] . Mag-mut induced the release of calcein from calcein-entrapped zwitterionic PC/Chol lipid vesicles, as shown by the dose-dependent increase in the percentage of fluorescence recovery ( Figure 5A ). However, magainin 2 failed to induce the release of calcein from these vesicles even at the peptide-to-lipid ratio of 0.12, the maximum used in this experiment. Nevertheless, when the negatively charged PC/PG vesicles were used, both of the peptides induced a similar and significant amount of calcein release from the calcein-entrapped lipid vesicles ( Figure 5B ).
Secondary structure of magainin 2 and Mag-mut
The activity of many antimicrobial peptides is correlated with their ability to adopt an amphipathic α-helical conformation upon interaction with biological membranes, therefore we investigated the ability of magainin 2 and Mag-mut to adopt an α-helical In the presence of PC/Chol lipid vesicles, magainin 2 failed to adopt a significant secondary structure. In contrast, Mag-mut adopted an appreciable helical structure in the presence of the same kind of lipid vesicles, as indicated by the characteristic CD spectrum ( Figure 6A ). Interestingly, in the presence of PC/PG lipid vesicle, both of the peptides adopted significant helical structures ( Figure 6B ). Taken together the results indicated a significant difference between magainin-2 and Mag-mut with respect to their secondary structures in zwitterionic lipid vesicles, although they adopted a similar helical structure in the negatively charged lipid vesicles.
Detection of self assembly of magainin 2 and Mag-mut in an aqueous environment
The propensity of magainin 2 and Mag-mut to self assemble in an aqueous environment was investigated by recording their dosedependent CD spectra and ANS binding in PBS (pH 7.4). It is evident that magainin 2 did not show a significant change in CD spectra with an increase in peptide concentration ( Figure 7A) ; the increment in CD (milli-degree) values around 222 nm was negligible up to the tested concentration (∼198 μM), thereby indicating that a major population of magainin 2 remained in the random coiled form, which prevented the self-association of these peptide molecules. On the other hand, Mag-mut displayed transition in the shape of the spectra and a significant increase Concentrations of the peptides were ∼31 μM. ᮀ, magainin 2; ᭺, Mag-mut.
in CD values at 222 nm ( Figure 7B ), suggesting self-association of these peptide molecules. To further support this observation, an ANS-binding experiment was performed. ANS is often used for detection of hydrophobic patches on the surface of proteins. Its fluorescence yield increases significantly upon transfer into a hydrophobic environment from an aqueous environment, and the emission maximum shifts towards a shorter wavelength [20] . ANS is used to detect the aggregation of peptide owing to its self-assembly, since this process involves the structuring of the peptide molecules which create well-defined hydrophobic faces. These hydrophobic faces drive the peptide chains to selfassemble with each other [7] . As shown in Figure 7 (C), free ANS exhibited an emission maximum at 528.5 nm which shifted to 493 nm in the presence of magainin 2 with some increase in fluorescence intensity. However, in the presence of Magmut, the emission maximum of ANS shifted further towards the shorter wavelength at 467.5 nm, with a significant enhancement in fluorescence intensity. Taken together, the results suggest that Mag-mut significantly self assembled in an aqueous environment as compared with the native molecule.
Magainin 2 and Mag-mut showed significant differences in affinity and assembly in zwitterionic lipid vesicles
The affinity of magainin 2 and its analogue Mag-mut for zwitterionic phospholipid vesicles [PC/Chol; 8:1 (w/w)] was determined by binding experiments using their NBD-labelled versions. Binding curves of the peptides were generated by recording their NBD-fluorescence signals with increasing PC/Chol concentrations and plotting these with respect to the lipid/peptide molar ratio ( Figures 8A and 8C) . The plot showed a gradual increase in fluorescence with an increase in lipid concentration as a result of progressive binding of the NBDlabelled peptides to the lipid vesicles. Binding isotherms of the peptides associated with their binding to lipid vesicles were generated by plotting X b * (molar ratio of bound peptide per 60 % of the total lipid) with respect to C f (the concentration of the free peptide) as has been reported previously [11] ( Figures 8B  and 8D ). Partition coefficients of the NBD-labelled magainin 2 and Mag-mut to PC/Chol lipid vesicles were estimated from the slopes of the binding isotherms after extrapolating to zero. The estimated partition coefficient for NBD-magainin 2 was ∼0.8 × 10 4 , which is similar to a previous report where the partition coefficient of magainin 2 was found to be ∼0.7 × 10 4 in POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) vesicles [25] . Interestingly, the estimated partition coefficient (∼2.4 × 10 4 ) of NBD-Mag-mut was higher than that of NBD-magainin 2, suggesting that introduction of the leucine zipper sequence in magainin 2 augmented its affinity towards zwitterionic lipid vesicles. The nature of the binding curve can also provide an idea about the assembly of a peptide in the membrane. The binding isotherm of NBD-magainin 2 in PC/Chol lipid vesicles tended to extend downwards ( Figure 8B ) and indicated a negative cooperativity [26] of binding of peptides molecules on to the lipid vesicles, and also suggested the absence of any large aggregates of magainin 2. However, the binding isotherm of NBD-Mag-mut was significantly different from its parent peptide. The binding isotherm of NBD-Mag-mut in PC/Chol lipid vesicles tended to extend downward considerably and deviated from linearity ( Figure 8D ). As suggested previously, this kind of curve indicates the co-operativity in binding of peptide molecules to phospholipid membrane [27, 28] and the formation of the large aggregates of the peptide molecules therein. Thus, taken together, the results suggested that introduction of the leucine zipper sequence in magainin 2 induced a higher affinity for mammalian membranemimetic zwitterionic lipid vesicles, as well as enabled it to form large aggregates.
Detection of sizes of peptide-induced pores in CHO-K1 cells
This experiment was performed on live CHO-K1 cells as described in the Experimental section. Pore sizes were determined by estimation of influx of different sizes of fluorescent markers, which include calcein and FITC-tagged dextrans. No influx of calcein/FITC-dextrans occurred before addition of any peptide (results not shown). After 2-3 min of addition of ∼25 μM magainin 2 (doped with 2 % Rho-labelled magainin 2), all of the markers internalized into the cells ( Figure 9A , left-hand panels). The percentage of influx continuously decreased with an increase in the size of the marker. However, even the biggest marker, 250 kDa FITC-dextran (diameter ∼23 nm), showed significant influx (∼25 %) ( Figure 9B ). Interestingly, after the addition of ∼10 μM Mag-mut (doped with 2 % Rho-labelled Mag-mut) 20 kDa FITC-dextran (diameter ∼6.6 nm) was the biggest marker which efficiently internalized into the CHO-K1 cells ( Figure 9A , right-hand panels). Influx of 20 kDa FITC-dextran was ∼35 % (Figure 9B ), however, markers larger than 20 kDa did not show significant permeation into the cells. The morphology of peptide-bound cells was distorted in comparison with peptideunbound cells, which are indicated by arrowheads. Moreover, internalization of markers occurred only in those cells to which peptides were bound, thus ruling out the possibility of non-specific entry into the cells. The results indicated a difference in pore sizes formed by magainin 2 and Mag-mut on to the mammalian CHO-K1 cells. 
DISCUSSION
In the present study a novel analogue (Mag-mut) of a widely studied antimicrobial peptide magainin 2 has been designed to incorporate a leucine-zipper-like sequence in it without compromising the amino acid composition of the native peptide. We hypothesized that a leucine zipper sequence is a key structural element to induce toxicity in an antimicrobial peptide. Since the amino acid composition of Mag-mut was kept identical with the parent molecule magainin 2, the mean hydrophobicity of Magmut remain unaltered, and the observed changes in biological activity could be attributed to the inclusion of this leucinezipper-like sequence which is originally absent in the native molecule. Moreover, the hydrophobic moment of Mag-mut is the same as magainin 2 using Eisenberg's scale, suggesting that both of them possess very similar amphipathicity ( Figure 1A) . Interestingly, Mag-mut displayed significantly enhanced toxicity towards mammalian cells, as determined by a haemolytic activity assay against hRBCs and a cell viability assay against murine 3T3 and CHO-K1 cells (Figure 2) . However, the antibacterial activity of Mag-mut was largely unaffected by the inclusion of this structural element, as indicated by the antibacterial activity data (Table 1 ). These observations are consistent with our previous studies [5] [6] [7] 12] which showed a drastic effect of substitution of leucine residue(s) in the 'a' and/or 'd' position(s) of the leucine zipper sequence by alanine residue(s) on the cytotoxic, but not bactericidal activity of these antimicrobial peptides.
Rho-labelled magainin 2 did not appreciably bind to mammalian cells, as shown by its poor localization on to hRBCs ( Figure 3A) . However, Rho-labelled Mag-mut showed appreciable binding and strong localization on to hRBC membranes ( Figure 3A) . Moreover, a careful look at the DIC panels of Figure 3 revealed that Rho-labelled magainin 2-treated hRBCs were more distinguishable from the background than those hRBCs which were treated with Rho-labelled Mag-mut. The results probably indicated that Mag-mut altered the morphology of hRBCs. However, when the same experiment was performed with the Gram-positive bacteria B. megaterium, both magainin 2 and Mag-mut localized on to the bacterial membrane in a similar manner ( Figure 3B ). These results suggest that the introduction of a leucine zipper sequence in magainin 2 induced a stronger affinity towards hRBC membranes. The depolarization of hRBCs was induced only by Mag-mut (Figure 4 ), but not its parent peptide magainin 2, which clearly indicated that Mag-mut is capable of disrupting the integrity of hRBC membranes, unlike the native peptide. The lipid composition of mammalian membranes is quite different from that of bacterial membranes. Therefore distinction in the activity of magainin 2 and Mag-mut towards mammalian membrane may be ascribed to strong affinity of Magmut for the lipid composition of mammalian membranes. To confirm this possibility and to gain insight into the mechanism-ofaction, peptide-induced leakage of calcein from calcein-entrapped zwitterionic PC/Chol [8:1 (w/w)] and negatively charged PC/PG [7:3 (w/w)] lipid vesicles was studied ( Figure 5 ). PC/Chol [8:1 (w/w)] was used to mimic the outer leaflet of mammalian cell membranes [23, 24] , since it is mostly composed of zwitterionic lipids and Chol. Bacterial membrane is negatively charged and contains both negatively charged lipids, such as PG, and zwitterionic lipids, such as PE (phosphatidylethanolamine). Since PC is also zwitterionic, in a similar manner as PE, we have used PC/PG [7:3 (w/w)] as a mimetic of bacterial membranes, like many other researchers [23, 24] . Mag-mut and magainin 2 induced comparable leakages in PC/PG lipid vesicles which were consistent with their similar antibacterial activities ( Figure 5 ). Mag-mut started inducing leakage in PC/Chol lipid vesicles at a peptide-to-lipid ratio as low as 0.01, apparent by a >10 % fluorescence recovery due to the leakage of the dye, whereas magainin 2 was not effective in inducing any significant leakage even up to a peptide-to-lipid ratio of 0.12, the highest peptideto-lipid ratio examined ( Figure 5A ). It was demonstrated that a peptide-to-lipid ratio as high as ∼1.0 was required to observe significant dye leakage from PC bilayers by F12W-magainin 2, which is an analogue of magainin 2 which has similar activity [29] . These results have an important implication regarding the mechanism-of-action of Mag-mut against mammalian cells. Formation of a toroidal pore requires a lesser number of peptide chains per pore, which is reflected by dye leakage at a low peptideto-lipid ratio by Mag-mut. In a carpet-like mechanism-of-action, peptide chains cover the surface of membranes in a carpet-like manner and dissolves it like a detergent beyond a threshold concentration for which a high peptide-to-lipid ratio is required [30, 31] . Further evidence to support a distinct mode-of-action of magainin 2 and Mag-mut against mammalian cells was obtained by estimation of sizes of pores formed by these peptides on to CHO-K1 cells (see below).
Adoption of an amphipathic α-helical conformation is one of the primary steps in the peptide-membrane interactions of many antimicrobial peptides which could be important for regulating its activity towards different cell types. CD studies showed that only Mag-mut, but not the native peptide, adopted an appreciable helical structure in the mammalian membrane mimetic PC/Chol lipid vesicles ( Figure 6 ). However, in bacterial membrane mimetic PC/PG lipid vesicles, both peptides adopted a significant and similar helical structures ( Figure 6 ). The results indicated that magainin-2 possesses the primary amino acid sequence to adopt a helical structure in negatively charged lipid vesicles, but not in the presence of zwitterionic lipid vesicles. Although Mag-mut contains the same amino acid composition, introduction of a leucine zipper sequence induced a significant helical secondary structure of this molecule in the presence of zwitterionic lipid vesicles too. In fact many cytotoxic antimicrobial peptides, such as melittin, bombolitins and pardaxin, acquire helical structures in the presence of zwitterionic lipid vesicles [5, 32, 33] . Furthermore, the non-toxic analogues of melittin, as well as the non-toxic alanine-substituted designed leucine zipper peptides, failed to adopt an appreciable secondary structure in zwitterionic lipid vesicles, in a similar manner to melittin and the original leucine zipper peptide respectively [5, 12] . The self-assembly of antimicrobial peptides in an aqueous environment has been reported to play a role in their toxicity [5, 12, 34, 35] . Dose-dependent CD studies revealed that magainin 2 was present predominately as random coils in an aqueous environment, which is in agreement with similar studies on magainin 2 [36, 37] . Furthermore, the computational program AGADIR predicted a significantly lower helical structure of magainin 2 in an aqueous environment ( Figure 1A ) as compared with Mag-mut. Mag-mut displayed a gradual increase in helicity with increasing concentration, thereby indicating formation of aggregates ( Figure 7 ). This notion is further supported by the ANS-binding experiment ( Figure 7C ). Magmut induced a significant blue-shift in the emission maximum of ANS, as well as a large increase in its fluorescence intensity as compared with magainin 2. This propensity of Mag-mut to self assemble in an aqueous environment most probably originated from its possession of a leucine-zipper-like sequence which has already been reported to influence self assembly of melittin and synthetic leucine zipper peptide [5, 12, 38] , and other peptides and proteins also [39, 40] . As indicated by the previous studies and the literature, peptide-membrane interactions play a crucial role in determining the activity of these membrane-active antimicrobial peptides. Since magainin 2 and Mag-mut showed significant differences with respect to their activity against hRBCs and other mammalian cells, the interaction of these peptides with mammalian membrane-mimetic zwitterionic lipid vesicles PC/Chol [8:1 (w/w)] was studied. Mag-mut showed higher affinity than native magainin 2 for zwitterionic lipid vesicles (Figure 8 ), which supported their binding and localization studies on to the mammalian cells by confocal microscopic techniques (Figure 3) . It was also revealed that Mag-mut, but not magainin 2, bound co-operatively on to the zwitterionic lipid vesicles forming large aggregates therein. Since aggregation of the peptide molecules on to the membrane is expected to cause substantial disturbance on to the lipid bilayer [31, 41] , formation of large aggregates by the toxic analogue of magainin 2 in mammalian membrane mimetic zwitterionic lipid vesicles could be an important step towards its exhibition of cytotoxicity. Many haemolytic, pore-forming toxin or toxin fragments showed aggregation properties while interacting with zwitterionic lipid vesicles [27, 28] . Moreover, the amino acid substitution which impaired the aggregation properties of these peptides in this kind of lipid vesicles also abrogated their cytotoxicity [7, 27, 28, 42] .
To determine the mechanism of toxicity of Mag-mut and discriminate it from its native peptide magainin 2, sizes of these peptide-induced pores on to CHO-K1 cells were estimated. CHO-K1 cells were employed as a model mammalian cell, which was also used by others for estimating the sizes of the pores induced by magainin 2 [21] . The results suggest that pores induced by magainin 2 in CHO-K1 cells were of various diameters, as markers of different sizes permeated into the cells in its presence (Figure 9 ). It should be mentioned that the absence of a finite-sized pore is a hallmark of the carpet mechanism, which involves formation of transient pores in the membrane that may ultimately lead to their disintegration [31] . Our observation on the possible involvement of a carpet mechanism on magainin 2-induced pores in CHO-K1 cells is also consistent with a previous and similar study on magainin 2 [21] . Interestingly, pores induced by Mag-mut showed an upper limit of ∼9.0 nm since internalization of marker of this diameter (40 kDa) was prevented. The average size of the pores induced by Mag-mut was estimated to be in the range of ∼2.8-6.6 nm, as shown by significant infiltration of markers whose sizes are in this diameter range ( Figure 9B ). This range of pore diameter complies with the toroidal pore model, as suggested for other peptides which have been proposed to act via this particular model of pore formation [43] [44] [45] . Furthermore, Mag-mut-induced permeabilization of CHO-K1 cells by the toroidal pore model matched with the aggregation property of this peptide in the presence of zwitterionic lipid vesicles ( Figure 9 ). This is because cationic antimicrobial peptides which act through the barrel-stave or toroidal pore mechanism seem to aggregate before or during destabilizing the target bilayer [31, 41] . The cytotoxic peptide melittin and sticholysin I and II also destabilize mammalian cell membranes by the toroidal pore model [43, 46, 47] . Lack of appreciable helix content of magainin 2 in zwitterionic lipid vesicles also supports its model of permeabilization of the mammalian cell membrane by the carpet mechanism which is involved with a less-ordered structure of peptides [30, 31] .
There are reports in which the disulfide-linked dimeric analogues of magainin 2 showed enhanced haemolytic activity than the corresponding monomeric versions. Tencza et al. [48] suggested that the presence of the dimeric form of a peptide can provide a starting point to promote oligomerization by shifting equilibrium in favour of oligomer [48] . Similarly Dempsey et al. [49] reported that the process of pore formation by a monomeric version of a peptide is more concentration-dependent than its dimeric version, which indicated that the self aggregation of a peptide on the surface of a biological membrane is a crucial determinant in the origin of a pore [49] . In another study by Unger et al. [50] , a cyclic magainin 2 analogue was shown to possess decreased cytotoxicity, which was correlated with its decreased secondary structure and reduced affinity towards the model membrane. All of these observation were in agreement with our present study in which secondary structure, membraneaffinity and ability to self-associate govern the activity of the designed magainin-analogue towards mammalian cells.
In our previous studies the toxicity of leucine-zipper-containing peptides were reduced by replacing their heptadic leucines with alanine residues. In the present study we adopted a retro approach and converted an otherwise non-toxic molecule into a toxic molecule by introducing leucine/isoleucine residues at heptadic positions, thus providing direct evidence, for the first time, in favour of the involvement of a leucine-zipper-like sequence in controlling toxicity of an antimicrobial peptide. Taken together the results of the present study provide evidence to recognize the leucine zipper sequence as a switch to regulate toxicity of antimicrobial peptides which possess this structural element. Magainin 2 is one of the first extensively characterized antimicrobial peptides, and one of the reasons for focus on this molecule is its low toxicity; yet very little is known about the basis of the low toxicity of this naturally occurring antimicrobial peptide, and the present study emphasizes this issue.
Conclusion
The introduction of a leucine zipper sequence in a novel analogue of magainin-2 (Mag-mut) significantly altered its localization, secondary structure and mode of interaction towards the mammalian cell membranes, as well as mammalian cell membrane mimetic zwitterionic PC/Chol lipid vesicles, as compared with the native peptide magainin 2. Furthermore, Mag-mut, but not magainin 2, showed significant self-assembly properties in an aqueous environment, as well as in the presence of zwitterionic lipid vesicles. Probably, all of these alterations of structural and functional properties in Mag-mut as a result of the introduction of a leucine zipper sequence are associated with induction of cytotoxicity in this peptide. Perhaps the inability of magainin 2 to self-assemble in aqueous and mammalian membrane mimetic zwitterionic phospholipid vesicles is the clue behind its lesser cytotoxicity against mammalian cells. This is valuable information which could aid in the strategies of controlling toxicity of potent antimicrobial peptides, thereby paving the way to design novel cell-selective molecules of therapeutic potential.
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